Live Breaking News & Updates on மெய்நிகர் காங்கிரஸ்

Stay updated with breaking news from மெய்நிகர் காங்கிரஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Forma Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update - Press Release

Forma Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update - Press Release
wiredprnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wiredprnews.com Daily Mail and Mail on Sunday newspapers.

United States , Johne Bishop , Frank Lee , American Society Of Clinical Oncology , European Hematology Association , Drug Administration , Epizyme Inc , Virtual International Conference On Molecular , Exchange Commission , Development Rd Expenses , Forma Therapeutics Holdings Inc , Virtual Congress , Program In Prostate Cancer , Program In Sickle Cell Disease , International Conference , Molecular Targets , American Society , Clinical Oncology , Therapeutics Holdings , Sickle Cell Disease , Prostate Cancer , Cancer Therapeutics , Daylight Time , Private Securities Litigation Reform Act , Quarterly Report , United States Securities ,

Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones

Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Davida Spellman , Stevenk Burke , Kristenk Sheppard , Johnp Butler , Drug Administration , Research Development , Exchange Commission , Akebia Therapeutics Inc , Otsuka Pharmaceutical Co , European Medicines Agency , Virtual Congress , European Renal Association , England Journal , Chief Executive Officer , Senior Vice President , Chief Medical Officer , Otsuka Pharmaceutical , Marketing Authorization Application , Business Highlights , Prescription Drug User Fee Act , Transplant Association , Chief Financial Officer , New Drug Application , Chronic Kidney Disease ,

Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results and Provides a Corporate Update

Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results and Provides a Corporate Update
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Viia Fviia , Tom Knudsen , Nassim Usman , Howard Levy , Filomeen Haerynck , Systemic Complement Program , Drug Administration , International Society For Thrombosis , Catalyst Biosciences Inc , Exchange Commission , University Of Ghent , Virtual Congress , Company Quarterly Report On Form , Catalyst Biosciences , Fast Track Designation , International Society , Complement Program , Grant Blouse , Safety Monitoring Board , Protease Medicines , Quarterly Report , Consolidated Statements , Months Ended June , டோம் நட்‌ஸெந் , ந்யாஸைம் உஸ்மேன் , ஹோவர்ட் வசூல் செய்தல் ,

Aptose Reports Results for the Second Quarter 2021

Aptose Reports Results for the Second Quarter 2021
Aptose Biosciences Inc. a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, today announced financial results for the three months ended June 30, 2021 and provided a corporate update. The net loss for the quarter ended June 30, 2021 was $13.5 million compared with $15.8 million for the quarter ended June 30, 2020. The net loss for the six months ended …
– Conference call and webcast at 5:00 pm EDT today –
– Luxeptinib Phase 1a/b studies in AML and B cell malignancies fully enrolled at 750 mg dose –
– APTO-253 Phase 1a/b study in AML / MDS treating patients at sixth dose cohort of 210 mg/m2 – ....

United States , Aptose Biosciences , Susan Pietropaolo , Exchange Commission , Lifesci Advisors , Aptose Biosciences Inc , Corporate Communications Investor Relations , Virtual Congress , Luxeptinib Phase , Chief Executive , Clinical Study , B Cell Malignancies , North American , Investor Relations , United States Securities , Sci Advisors , Managing Director , ஒன்றுபட்டது மாநிலங்களில் , பரிமாற்றம் தரகு , பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் , மெய்நிகர் காங்கிரஸ் , தலைமை நிர்வாகி , மருத்துவ படிப்பு , வடக்கு அமெரிக்கன் , முதலீட்டாளர் உறவுகள் , ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் ,

Protagonist Therapeutics Reports Second Quarter 2021 Financial Results and Recent Company Progress

Protagonist Therapeutics Reports Second Quarter 2021 Financial Results and Recent Company Progress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Dineshv Patel , Janssen Biotech Inc , Prnewswire Protagonist Therapeutics Inc , European Hematology Association , Protagonist Therapeutics Inc , Exchange Commission , Development Rd Expenses , Drug Administration Breakthrough Therapy Designation , Virtual Congress , Chief Executive , Drug Administration , Breakthrough Therapy , Subcutaneous Injectable Hepcidin Mimetic , Polycythemia Vera , Breakthrough Therapy Designation , Janssen Biotech , Protagonist Collaboration , Cash Equivalents , Marketable Securities , Collaboration Revenue , Private Securities Litigation Reform Act , Consolidated Statements , Months Ended , ஒன்றுபட்டது மாநிலங்களில் , ஜான்சன் பயோடெக் இன்க் ,